| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5690679 | Gynecologic Oncology | 2016 | 6 Pages |
Abstract
In this prospective window of opportunity study, we demonstrated that relevant serum and molecular changes occur in patients with newly diagnosed EC after a short course of metformin. Ongoing clinical trials will help determine the appropriate role for metformin in the treatment of women with EC.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Pamela T. Soliman, Qian Zhang, Russell R. Broaddus, Shannon N. Westin, David Iglesias, Mark F. Munsell, Rosemarie Schmandt, Melinda Yates, Lois Ramondetta, Karen H. Lu,